Pediatric considerations for the development of medicines

1:33:44

Best practices in accessible clinical trial design

1:00:08

Not all measures matter: How to identify outcomes measures appropriate for your rare disease patient populations

1:02:01

Unique considerations around accessibility for global clinical trials

1:02:00

Meeting trial participants where they’re at: Where DCTs can help achieve greater accessibility

59:57

Accessibility in rare disease paediatric clinical trials

1:00:15

Where do expanded access programmes fit into trial accessibility?

59:43

Is disability part of your DEI planning and engagement in rare disease?

59:24

Webinar: Diversity, Equity and Inclusion in Rare Disease Clinical Trials

1:14:41

Webinar: Hot flashes, brain fog and the blues

58:34

Patient-centric trial development toolkit - rare diseases

57:01

Reflections on paediatric assent: Have we outgrown this concept?

In this webinar, medical ethicists will discuss what investigators, ethics committees, IRBs and – ideally – sponsors can do to reverse this trend and create documents which achieve their intended purpose of allowing a child to understand their trial.

1:02:52